A study found patients treated with Pacira Pharmaceuticals' EXPAREL experienced statistically significant lower rates of urinary retention, respiratory depression and fall risk compared to their counterparts in a control group.
The data was presented at the American College of Surgeons Clinical Congress in San Francisco, from Oct. 26 to Oct. 30.
For the study, 82 patients undergoing open ventral hernia repair or laparoscopic colon resection were examined. Thirty-seven patients received the previous standard of care. The remaining patients received infiltration with EXPAREL in addition to the standard of care.
Key findings of the study include:
• No patient in the EXPAREL group experienced urinary retention, as compared to 10.8 percent in the standard of care group.
• A little over 2 percent of patients experienced respiratory depression in the EXPAREL group versus 21.6 percent in the SOC group.
• Use of EXPAREL reduced the amount of patients classified as being "high-risk" for falls.
More articles on spine:
Two-level spine surgery economic analysis: Disc replacement vs. ACDF
How does obesity impact lumbar spine treatment? 5 key findings
3 trends in ASC spine care